Euglycemic diabetic ketoacidosis is a rare but serious side effect of SGLT2 inhibitor treatment, occurring mainly in diabetes with insulin deprivation, after surgery [153] or under infectious conditions [154]. The gene discussed is SLC5A2; the disease is diabetes mellitus.